指南与共识胸部肿瘤

县域与地市级医疗机构肺癌病理诊断专家共识(2025版)

[Expert consensus on pathological diagnosis of lung cancer in county-level and prefectural medical institutions (2025 edition)].
指南 / 共识 · Zhonghua Zhong Liu Za Zhi · 2025-01-01

中国抗癌协会肿瘤病理专业委员会肺癌学组组织专家制定本共识,针对县域与地市级医疗机构病理科整体建设滞后、诊断水平参差、先进技术不可及等问题,围绕细胞学、活检及手术切除三类样本,从标本前处理、形态评估、免疫组化、特殊染色与分子检测及规范化报告五方面形成推荐。共识采用德尔菲问卷调查与共识会议法(线上与线下结合)形成推荐条款与级别,并涵盖新辅助治疗后病理评估及术中冰冻诊断,侧重规范性与可行性。

要点

  • 覆盖细胞学、活检与手术切除三类标本的全流程病理诊断规范。
  • 从标本前处理、形态评估、免疫组化、特殊染色与分子检测、规范化报告五方面构建框架。
  • 纳入新辅助治疗后病理评估与术中冰冻诊断等临床关注问题。

核心结论

  • 共识旨在推动县域与地市级医疗机构肺癌病理诊断规范化,为临床诊疗与预后评估提供指导性建议。

研究设计与样本

  • 由中国抗癌协会肿瘤病理专业委员会肺癌学组组织专家制定,采用德尔菲问卷调查法与共识会议法,线上与线下结合形式形成推荐及推荐级别。

主要发现

  • 共识分别针对肺癌细胞学、活检及手术切除3种样本类型构建并展开推荐框架。
  • 共识框架涵盖标本规范化前处理、形态学病理评估、免疫组化、特殊染色和分子病理检测及规范化报告5个方面。
  • 共识同时纳入肺癌新辅助治疗术后病理评估及术中冰冻诊断等行业关注问题。

关键数值与推荐

  • 推荐条款及推荐级别采用德尔菲问卷调查法和共识会议法形成。
  • 共识侧重县域与地市级医疗机构应用的规范性与可行性。

临床怎么用

  • 县域与地市级医疗机构可参照本共识规范肺癌细胞学、活检及手术切除标本的病理诊断全流程。
  • 临床可依据规范化病理报告进行肺癌诊疗决策与预后评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lung cancer is the malignant tumor with the highest morbidity and mortality in China. Standardized pathological diagnosis of lung cancer is crucial for determining clinical strategy and evaluating prognosis. Currently, there are issues such as relatively lagging overall construction, uneven diagnostic levels and inaccessibility to advanced diagnostic techniques in the pathology departments of county-level and prefectural medical institutions within the close-knit medical alliance in China. To implement the national policy on the hierarchical diagnosis and treatment of lung cancer, standardize the pathological diagnosis of lung cancer in county-level and prefectural medical institutions to meet the basic needs of lung cancer diagnosis and treatment, and support the advancement of the Healthy China strategy and the construction of a close-knit medical alliance, experts were organized by the Lung Cancer Group of the Pathology Committee of the China Anti-Cancer Association, to develop comprehensive consensus recommendations and their levels to promote the standardization of the entire process of lung cancer pathological diagnosis. This was done by combining domestic and international guidelines and current domestic situation, focusing on three types of specimen: cytology, biopsy and surgical resection. The consensus framework is constructed and elaborated from five aspects: pre-processing of specimen standardization, morphological pathological assessment, immunohistochemistry, special staining, molecular pathological detection and standardized reporting. It also covers issues of concern in industry such as postoperative pathological assessment after neoadjuvant therapy and intraoperative frozen diagnosis. During the process of consensus formation, the Delphi questionnaire survey and consensus conference method were used, by combination of online and offline forms. The consensus focuses on the standardization and feasibility of application, aiming to promote the standardization of lung cancer pathological diagnosis and provide guiding suggestions for clinical diagnosis, treatment, and prognosis evaluation of lung cancer in county-level and prefectural medical institutions. 肺癌是中国发病率及死亡率均位居首位的恶性肿瘤,规范的肺癌病理诊断对临床治疗方案的确定和患者预后评估至关重要。目前中国地市和县域紧密型医联体医疗机构病理科存在整体建设稍滞后、病理诊断水平参差不齐、先进诊疗技术不可及等问题。为落实全国肺癌整体分级诊疗政策、规范地市和县域肺癌病理诊断以满足肺癌诊治基本需求,配合推进健康中国战略和紧密型医联体建设,由中国抗癌协会肿瘤病理专业委员会肺癌学组组织专家,结合国内外指南和国内相关现状,分别对肺癌细胞学、活检及手术切除3种样本类型,从标本规范化前处理、形态学病理评估、免疫组化、特殊染色和分子病理检测及规范化报告5个方面构建框架并展开,同时还包括了肺癌新辅助治疗术后病理评估及术中冰冻诊断等行业关注问题;采用德尔菲问卷调查法和共识会议法,以线上、线下结合形式,最终形成能覆盖肺癌病理诊断全方位、全流程的共识推荐及推荐级别。共识侧重地市和县域医疗机构应用的规范性及可行性,旨在推动相应层级医疗机构规范化肺癌病理诊断以期为临床诊疗和预后评估提供指导性建议。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. [Expert consensus on pathological diagnosis of lung cancer in county-level and prefectural medical institutions (2025 edition)]. Zhonghua Zhong Liu Za Zhi. 2025. PMID: 41443727. doi:10.3760/cma.j.cn112152-20250428-00188

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。